Conflicts of interest: None.
Pharmacology and therapeutics
Use of oxybutynin for treating plantar hyperhidrosis
Version of Record online: 17 APR 2013
© 2013 The International Society of Dermatology
International Journal of Dermatology
Volume 52, Issue 5, pages 620–623, May 2013
How to Cite
Wolosker, N., de Campos, J. R. M., Kauffman, P., Yazbek, G., Neves, S. and Puech-Leao, P. (2013), Use of oxybutynin for treating plantar hyperhidrosis. International Journal of Dermatology, 52: 620–623. doi: 10.1111/j.1365-4632.2012.05746.x
- Issue online: 17 APR 2013
- Version of Record online: 17 APR 2013
To evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses for treating plantar hyperhidrosis.
From January 2007 to December 2010, 35 consecutive patients with plantar hyperhidrosis were treated with oxybutynin. Data were collected from 30 patients (five patients were lost to follow-up). During the first week, patients received 2.5 mg of oxybutynin once a day, 2.5 mg twice a day from the eighth to the 42nd day, and from the 43rd day to the end of the 12th week, 5 mg twice a day. All of the patients underwent two evaluations: before and after the oxybutynin treatment, using a clinical questionnaire, and a clinical protocol for quality of life.
More than 70% of patients experienced an improvement in plantar hyperhidrosis. Most of the patients showed improvements in quality of life (66.6%). The side effects were minor, the most frequent being dry mouth (76.7%).
Treatment of plantar hyperhidrosis with oxybutynin presents good results and improves quality of life. We believe that this therapeutic alternative is an excellent choice for the initial treatment of plantar hyperhidrosis.